4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-043967
General Counsel sold 712 shares at $15.67 ($11,157)
- General Counsel acquired 1,924 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2022-07-30 | Option exercise | +1,924 | 5,327 | D: show line 1 in the form | ||
| Ring Christine General Counsel | 2022-08-01 | Sale | −712 | $15.67 | $11,157 | 4,615 | D: show line 2 in the form |
| Open-market sales · 712 sh · avg $15.67 · $11,157 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2022-07-30 | Option exercise · Restricted Stock Units | −1,924 | 26,937 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…